Vaping Cannabis Associated With More Respiratory Issues Than Vaping Tobacco, Study Finds
Teens who vape cannabis are almost twice as likely to report problems with wheezing and coughing than teens who smoke cigarettes or vape nicotine products, a new study has found.
A Microdosing High is Mostly a Placebo Effect, Psychedelic Study Suggests
People may not have to microdose psychedelics to feel their wellbeing benefits – they just have to believe they’ve microdosed them, according to researchers from Imperial College London.
Cannabis Can Cause “Rebound” Migraine Headaches, Study Finds
Migraine sufferers who use cannabis for pain relief may be at higher odds of developing a “rebound” headache, according to new research from Stanford University.
How Does Cannabis Vapor Testing Work?
Cannabis vapor testing is quickly becoming the next frontier of marijuana analysis. But how does it work?
High-CBD Hemp Crops Are Mostly Marijuana, Genetic Study Finds
Hemp crops may have more in common with recreational, “drug-type” varieties of cannabis than previously thought, according to new research from the University of Minnesota.
The Risks and Rewards of Different Cannabis Separation Techniques
Alisia Ratliff, CEO of Victus Capital Ventures, explores the world of cannabis separation techniques – the good, the bad, and the expensive.
Behind the World-First Export of Jamaican Psilocybin Mushrooms
The biotech and life sciences company Mydecine Innovations Group recently announced it had completed its first commercial export of legal psychedelic psilocybin mushrooms from Jamaica to Canada. Technology Networks caught up with the company's chief scientific officer, Rob Roscow, to find out more.
One Month Until the Deadline, There’s Still Some Confusion Around CBD Novel Foods Applications in the UK
Regulation is incoming for the UK's CBD industry. But are companies clued up on the new requirements? Not always, say CBD analysts, and the confusing guidance may be partly to blame.
MDMA-assisted Therapy a “Promising New Treatment” for PTSD, Finds Review
The researchers found MDMA-assisted psychotherapy to have a particularly “impressive effect size” in reducing PTSD symptoms. But they say more studies will be needed before the drug can be recommended for clinical practice.
